Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 2Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 41Non-Muscle Invasive Bladder Neoplasms 25Colorectal Neoplasms 21Carcinoma, Transitional Cell 17Anus Neoplasms 17Neoplasm Metastasis 12Carcinoma, Hepatocellular 11Appendiceal Neoplasms 11Stomach Neoplasms 10Peritoneal Neoplasms 9Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Lung Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Urologic Neoplasms 4Sarcoma 4Carcinoma 4Anal Canal Carcinoma 4Urologic Diseases 3Urogenital Neoplasms 3Urinary Bladder Diseases 3Recurrence 3Pseudomyxoma Peritonei 3Ovarian Neoplasms 3Neoplasms by Site 3Mesothelioma, Malignant 3Gastrointestinal Neoplasms 3

Interventions

Cyclophosphamide 153Dexamethasone 141Rituximab 85fludarabine 79Lenalidomide 72Cytarabine 70Bortezomib 64fludarabine phosphate 63Gemcitabine 62venetoclax 54Etoposide 53pomalidomide 52pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recurrence × Mitomycin × Clear all
NCT06781879 2025-10-03

COBRA-NMIBC

Aarhus University Hospital

Phase 4 Recruiting
272 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT05874921 2025-02-28

uTRACT

UroGen Pharma Ltd.

Recruiting
400 enrolled
Genitourinary

Carcinoma, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Neoplasms

NCT00644020 2008-03-26

Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡